2nd Joint DIA / EMA Innovation Forum: Is the EU Regulatory Framework Ready?
|Event Date/Time: Nov 29, 2010||End Date/Time: Nov 30, 2010|
â€¢ Current activities at EU level to ensure innovation in science translate into benefit for the patients and to public health. This includes the new pharmaceutical package, paediatric medicines, gene therapy and stem cells, information to patients, and European Commission impact assessment of the clinical trial directive
â€¢ Impact of the implementation of the 2007 Think-Tank report on the Agencyâ€™s activities and road map to 2015 to support enhanced regulatory decision-making and access to medicines
â€¢ Innovation in the pharmaceutical industry: looking for examples of innovative approaches in portfolio selection for R&D strategy
â€¢ Innovative medicines availability and unmet medical needs: role of regulators and policy makers
Who Will Attend